Pulsed Field Energy in Atrial Fibrillation Ablation: From Physical Principles to Clinical Applications
Journal of Clinical Medicine · 18.05.2024 · 13 (10) · 2980
DOI: 10.3390/jcm13102980 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.05.2024. Verfasst von Nicola Pierucci und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular, Respiratory, Nephrological, Aenesthesiological and Geriatric Sciences "Sapienza", University of Rome, 00161 Rome, Italy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atrial fibrillation, representing the most prevalent sustained cardiac arrhythmia, significantly impacts stroke risk and cardiovascular mortality. Historically managed with antiarrhythmic drugs with limited efficacy, and more recently, catheter ablation, the interventional approach field is still evolving with technological advances. This review highlights pulsed field ablation (PFA), a revolutionary technique gaining prominence in interventional electrophysiology because of its efficacy and safety. PFA employs non-thermal electric fields to create irreversible electroporation, disrupting cell membranes selectively within myocardial tissue, thus preventing the non-selective damage associated with traditional thermal ablation methods like radiofrequency or cryoablation. Clinical studies have consistently shown PFA’s ability to achieve pulmonary vein isolation—a cornerstone of AF treatment—rapidly and with minimal complications. Notably, PFA reduces procedure times and has shown a lower incidence of esophageal and phrenic nerve damage, two common concerns with thermal techniques. Emerging from oncological applications, the principles of electroporation provide a unique tissue-selective ablation method that minimizes collateral damage. This review synthesizes findings from foundational animal studies through to recent clinical trials, such as the MANIFEST-PF and ADVENT trials, demonstrating PFA’s effectiveness and safety. Future perspectives point towards expanding indications and refinement of techniques that promise to improve AF management outcomes further. PFA represents a paradigm shift in AF ablation, offering a safer, faster, and equally effective alternative to conventional methods. This synthesis of its development and clinical application outlines its potential to become the new standard in AF treatment protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular, Respiratory, Nephrological, Aenesthesiological and Geriatric Sciences "Sapienza", University of Rome, 00161 Rome, Italy.
- Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX 78705, USA.
ORCID-Profile: Nicola Pierucci, Marco Valerio Mariani, Domenico Laviola, Sara Trivigno, Vincenzo Mirco La Fazia, Agostino Piro, Fabio Miraldi, Carmine Dario Vizza
Zitieren
APA
Pierucci, N., Mariani, M. V., Laviola, D., Silvetti, G., Cipollone, P., Vernile, A., Trivigno, S., La Fazia, V. M., Piro, A., Miraldi, F., Vizza, C. D., & Lavalle, C. (2024). Pulsed Field Energy in Atrial Fibrillation Ablation: From Physical Principles to Clinical Applications. Journal of Clinical Medicine, 13(10), 2980. https://doi.org/10.3390/jcm13102980
Vancouver
Pierucci N, Mariani MV, Laviola D, Silvetti G, Cipollone P, Vernile A, et al. Pulsed Field Energy in Atrial Fibrillation Ablation: From Physical Principles to Clinical Applications. Journal of Clinical Medicine. 2024;13(10):2980. doi:10.3390/jcm13102980
BibTeX
@article{Pierucci2024,
author = {Pierucci, Nicola and Mariani, Marco Valerio and Laviola, Domenico and Silvetti, Giacomo and Cipollone, Pietro and Vernile, Antonio and Trivigno, Sara and La Fazia, Vincenzo Mirco and Piro, Agostino and Miraldi, Fabio and Vizza, Carmine Dario and Lavalle, Carlo},
title = {Pulsed Field Energy in Atrial Fibrillation Ablation: From Physical Principles to Clinical Applications},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {10},
pages = {2980},
doi = {10.3390/jcm13102980}
}
EUVIMED